Evogene Ltd
NASDAQ:EVGN

Watchlist Manager
Evogene Ltd Logo
Evogene Ltd
NASDAQ:EVGN
Watchlist
Price: 1.15 USD 2.68% Market Closed
Market Cap: 10m USD

Gross Margin
Evogene Ltd

50.2%
Current
21%
Average
63.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
50.2%
=
Gross Profit
2.6m
/
Revenue
5.2m

Gross Margin Across Competitors

No Stocks Found

Evogene Ltd
Glance View

Market Cap
10m USD
Industry
Biotechnology

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

EVGN Intrinsic Value
1.95 USD
Undervaluation 41%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
50.2%
=
Gross Profit
2.6m
/
Revenue
5.2m
What is the Gross Margin of Evogene Ltd?

Based on Evogene Ltd's most recent financial statements, the company has Gross Margin of 50.2%.

Back to Top